Weifang Weisenge plans to build 3000t/a Difenoconazole and Propiconazole projects
Recently, Changyi City People's Government on Weifang Weisenge Chemical Co., LTD. 3000t/a Difenoconazole and Propiconazole projects was published. The company plans to build a new 3000t/a Difenoconazole and Propiconazole projects in Longchi Chemical Industrial Park, Changyi City, Weifang City, Shandong Province. After the completion of the project, the annual output of 3,000 tons of Difenoconazole and Propiconazole or 5,000 tons of Difenoconazole bromide and Propiconazole bromide can be achieved.
Weifang Weisenge Chemical Co., Ltd. was incorporated in January 2009, located in Longchi Chemical Industry Park, Changyi City, Weifang City, Shandong Province. At present, the company's main products are Hydrobromic acid Hydrobromic acid in acetic acid, 2,2-Bis(bromomethyl)propane-1,3-diol
2026-10-04
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Shanghai Yuelian's innovative nano ME containing Fluxapyroxad hit the market
-
Jiangsu Chengyang plans to expand the 13,000 tons of pesticide projects such as Cyproconazole and Difenoconazole
-
China丨Limin will further expand the overseas market with registration of Difenoconazole
-
Syngenta introduced a variety of products in Brazil, such as Difenoconazole and Pydiflumetofen
-
There is a lack of pesticide product registration on lemons in China, and Fruit farmers have no choice, use is illegal
-
Adama launches five new cereal fungicides for the European market
-
EU Commission Reapproves Propiconazole as Active Substance in Fungicidal Products
-
Corteva launches Straxan™ fungicide seed treatment in Canada
-
Udragon’s 4600 t/a of pesticide technical project is progressing smoothly, and the main infrastructure is expected to be completed by the end of October
-
Best Agrolife launches Tricolor (Trifloxystrobin + Difenoconazole + sulfur)
Recommend Reading
-
McKinsey Pays to Close a Purdue Liability Chapter
-
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
Is Evonik’s Massive Global Expansion of Hydroxyl-Terminated Polybutadiene (HTPB) a Technological Ambition — or a Geopolitical Gamble?
-
Iran Conflict Leaves a Long Shadow on Drug Supply
-
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
Chinese Asphalt Market Sees Limited Transactions Before the Festival, May Rise Moderately After the Festival
-
Pre-holiday Dichloromethane Price Increase Fails to Continue
-
Premium Global Chemical Sourcing Requests (7 - 11 Feb, 2026)
-
Weak Supply and Demand Fundamentals Lead to Weak Polyethylene Market Performance
-
Sodium Benzoate (E211): Safety, Benzene Risk, and Preservative Uses